Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 054670461 approvals29 trials

Daehan Nupharm Co.,Ltd.

Official website

KOSDAQ-listed pharmaceutical company producing a diverse, low-volume portfolio of metabolic disease drugs, wellness injections, and veterinary medicines.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1984 and listed on KOSDAQ in 2002, Daehan Nupharm is a company specializing in prescription pharmaceuticals and veterinary medicines. It offers prescription drugs focused on metabolic diseases such as hypertension, dyslipidemia, and diabetes, and on peptic ulcer treatment, alongside non-reimbursed obesity and wellness injections using vitamins, minerals, and thymosin alpha, and veterinary medicines including animal treatments, nutritional supplements, and livestock vaccines, while expanding into stem-cell-based anti-aging and cell therapy products. Revenue is structured as a diversified, low-volume portfolio with no single product accounting for more than 10% of sales.

Products & technology

  • Prescription drugs (metabolic disease, peptic ulcer treatments)Treatment of chronic metabolic diseases including hypertension, dyslipidemia, and diabetes
  • Obesity and wellness injectionsPain management, vitamin/mineral supplementation, immune enhancement (thymosin alpha, etc.)
  • Veterinary medicines (treatments, nutritional supplements, livestock vaccines)Animal treatment for livestock and companion animals
  • Stem-cell-based anti-aging and cell therapy productsAnti-aging and cell therapy

Regulatory approvals

data.go.kr

459 Korean MFDS drug approvals · 1994–2026 / 2 Korean MFDS device approvals · 2015–2016

  • MFDS drugNutomibe OD Tab. 10/5mg2026-06-30
    Drug · Prescription · Approval202601873
  • MFDS drugNutomibe OD Tab. 10/20mg2026-06-30
    Drug · Prescription · Approval202601874
  • MFDS drugNutomibe OD Tab. 10/10mg2026-06-30
    Drug · Prescription · Approval202601875
  • MFDS drugMermaid Tab.2026-05-12
    Drug · OTC · Notification202601389
  • MFDS drugNP siseul Soft capsule2026-04-27
    Drug · OTC · Notification202601242
  • MFDS drugNP Vono Tab. 10mg2026-04-23
    Drug · Prescription · Approval202601198
  • MFDS drugNP Vono Tab. 20mg2026-04-23
    Drug · Prescription · Approval202601199
  • MFDS drugNu-arse Tab.2026-04-01
    Drug · OTC · Notification202600926
  • MFDS drugV-bella Inj.2026-03-23
    Drug · Prescription · Approval202600824
  • MFDS drugNu-alpha Tab2026-03-04
    Drug · OTC · Notification202600653
  • MFDS drugCafurin Plus BC Tab.2026-01-16
    Drug · OTC · Notification202600156
  • MFDS drugAlugat Suspension2026-01-06
    Drug · OTC · Notification202600040
Show 68 more
  • MFDS drugMucoran SR Tab. 150mg2025-10-15
    Drug · Prescription · Approval202502661
  • MFDS drugDHNP Acetaminophen Inj.2025-07-10
    Drug · Prescription · Approval202501743
  • MFDS drugNP Vita-B Tab.2025-02-07
    Drug · OTC · Notification202500265
  • MFDS drugNP Selen-C Tab.2025-02-07
    Drug · OTC · Notification202500266
  • MFDS drugDaehannupharm arginine premix inj2024-12-18
    Drug · Prescription · Approval202403001
  • MFDS drugEnpiflu Premix Inj.2024-09-03
    Drug · Prescription · Approval202402143
  • MFDS drugWezime Tab.2024-08-29
    Drug · OTC · Notification202402089
  • MFDS drugGitako Tab. 240mg2024-08-20
    Drug · OTC · Notification202402015
  • MFDS drugLiformin Duo XR Tab. 2.5/1000mg2024-03-22
    Drug · Prescription · Approval202400614
  • MFDS drugLiformin Duo XR Tab. 5/1000mg2024-03-22
    Drug · Prescription · Approval202400615
  • MFDS drugWeline Tab.2024-02-22
    Drug · OTC · Notification202400387
  • MFDS drugRapiduo Tab. 10/350mg2023-12-18
    Drug · Prescription · Approval202303359
  • MFDS drugENPYANGDUO TAB. 12.5/500MG2023-09-06
    Drug · Prescription · Approval202302662
  • MFDS drugENPYANGDUO TAB. 12.5/850MG2023-09-06
    Drug · Prescription · Approval202302663
  • MFDS drugENPYANGDUO TAB. 12.5/1000MG2023-09-06
    Drug · Prescription · Approval202302664
  • MFDS drugDAPAFORMIN SR TAB. 10/1000 MG2023-01-27
    Drug · Prescription · Approval202300347
  • MFDS drugDAPAFORMIN SR TAB. 10/500 MG2023-01-27
    Drug · Prescription · Approval202300366
  • MFDS drugZero-be Tab. 60mg2023-01-06
    Drug · Prescription · Approval202300157
  • MFDS drugNP DAPA TAB. 10MG2022-12-13
    Drug · Prescription · Approval202204478
  • MFDS drugZero-be Tab. 120mg2022-11-18
    Drug · Prescription · Approval202204145
  • MFDS drugNewtomega Soft Cap.2022-07-08
    Drug · Prescription · Approval202202839
  • MFDS drugDexBeta Tab.2022-05-16
    Drug · Prescription · Notification202202036
  • MFDS drugSitaformin XR Tab. 50/1000mg2022-05-13
    Drug · Prescription · Approval202202024
  • MFDS drugSitaformin XR Tab. 100/1000mg2022-05-13
    Drug · Prescription · Approval202202025
  • MFDS drugSitaformin XR Tab. 50/500mg2022-05-13
    Drug · Prescription · Approval202202026
  • MFDS drugTenelformin SR Tab. 10/750mg2022-04-04
    Drug · Prescription · Approval202201318
  • MFDS drugTenelformin SR Tab. 10/500mg2022-04-04
    Drug · Prescription · Approval202201319
  • MFDS drugTenelformin SR Tab. 20/1000mg2022-04-04
    Drug · Prescription · Approval202201320
  • MFDS drugENPYANGDUO TAB. 5/1000MG2022-04-04
    Drug · Prescription · Approval202201379
  • MFDS drugENPYANGDUO TAB. 5/850MG2022-04-04
    Drug · Prescription · Approval202201380
  • MFDS drugENPYANGDUO TAB. 5/500MG2022-04-04
    Drug · Prescription · Approval202201381
  • MFDS drugDermabex gel2022-03-15
    Drug · OTC · Notification202201067
  • MFDS drugDinudex Inj.2022-02-08
    Drug · Prescription · Approval202200596
  • MFDS drugDuogli Tab.2022-01-28
    Drug · Prescription · Approval202200497
  • MFDS drugSitaforminAlpha Tab. 50/1000mg2022-01-06
    Drug · Prescription · Approval202200111
  • MFDS drugSitaforminAlpha Tab. 50/500mg2022-01-06
    Drug · Prescription · Approval202200112
  • MFDS drugSitaforminAlpha Tab. 50/850mg2022-01-06
    Drug · Prescription · Approval202200113
  • MFDS drugSelene Peroral Tab.2021-11-03
    Drug · OTC · Notification202107305
  • MFDS drugDHNP Minoxidil Tab.Revoked2021-06-23
    Drug · Prescription · Notification202104812
  • MFDS drugENPYANG TAB. 25mg(EMPAGLIFLOZIN)2021-03-05
    Drug · Prescription · Approval202102113
  • MFDS drugENPYANG TAB. 10MG(EMPAGLIFLOZIN)2021-03-05
    Drug · Prescription · Approval202102114
  • MFDS drugNewtozet Tab. 10/10mg2021-02-18
    Drug · Prescription · Approval202101604
  • MFDS drugNewtozet Tab. 10/20mg2021-02-18
    Drug · Prescription · Approval202101608
  • MFDS drugNewtozet Tab. 10/40mgRevoked2021-02-18
    Drug · Prescription · Approval202101609
  • MFDS drugCelBro inj.Revoked2021-01-06
    Drug · Prescription · Notification202100128
  • MFDS drugDeahannewpharm tofacitinib Tab.Revoked2021-01-05
    Drug · Prescription · Approval202100040
  • MFDS drugTeneltin Tab. 20mg (Teneligliptin)2020-12-31
    Drug · Prescription · Approval202009427
  • MFDS drugCambel Double Tab.2020-11-12
    Drug · OTC · Notification202007784
  • MFDS drugA.V.A-tri tab. 5/80/20mg2020-09-25
    Drug · Prescription · Approval202006659
  • MFDS drugA.V.A-tri tab. 5/80/10mg2020-09-25
    Drug · Prescription · Approval202006660
  • MFDS drugA.V.A-tri tab. 5/160/20mg2020-09-25
    Drug · Prescription · Approval202006661
  • MFDS drugA.V.A-tri tab. 5/160/10mg2020-09-25
    Drug · Prescription · Approval202006662
  • MFDS drugMELFIT PR Tab. 2mg(Melatonin)2020-09-22
    Drug · Prescription · Approval202006548
  • MFDS drugSitatin Alpha Tab. 100mg2020-05-29
    Drug · Prescription · Approval202004067
  • MFDS drugSitatin Alpha Tab. 50mg2020-05-29
    Drug · Prescription · Approval202004068
  • MFDS drugSitatin Alpha Tab. 25mgRevoked2020-05-29
    Drug · Prescription · Approval202004069
  • MFDS drugOlroduet Tab. 20/10mg2020-05-28
    Drug · Prescription · Approval202003972
  • MFDS drugOlroduet Tab. 20/5mg2020-05-28
    Drug · Prescription · Approval202003973
  • MFDS drugOlroduet Tab. 20/20mg2020-05-28
    Drug · Prescription · Approval202003974
  • MFDS drugMega-3 Soft Cap.Revoked2020-05-21
    Drug · Prescription · Approval202003721
  • MFDS drugPolezing Tab.Revoked2020-05-15
    Drug · Prescription · Approval202003553
  • MFDS drugNewdoba SR Cap.Revoked2020-05-14
    Drug · Prescription · Approval202003493
  • MFDS drugMosagatin SR Tab. 15mg2020-04-28
    Drug · Prescription · Approval202003107
  • MFDS drugTalosin ST Tab. 0.4mg2020-04-17
    Drug · Prescription · Approval202002731
  • MFDS drugPrelain Enteric Coated Tab. 100mg (Bromelain)Revoked2020-04-10
    Drug · OTC · Notification202002569
  • MFDS drugPlanline Tab. 45mg2020-04-08
    Drug · OTC · Notification202002484
  • MFDS drugFuzole Cap. 150mg2020-03-30
    Drug · Prescription · Approval202002190
  • MFDS drugDHNP Albendazole Tab.Revoked2020-03-05
    Drug · OTC · Notification202001553

Showing the 80 most recent of 461 records.

Clinical trials

data.go.kr

29 MFDS clinical trial authorisations · 2015–2025 (Bioequivalence 24 · Phase 1 5)

  • BioequivalenceDHNP-25012025-11-07

    2 trial sites

  • Phase 1DHNP-24012025-05-07

    2 trial sites

  • Phase 1DHNP-22032025-04-08

    2 trial sites

  • Phase 1DHNP-22032024-11-26

    2 trial sites

  • Bioequivalence무코란서방정150밀리그램(레바미피드)2024-03-26

    2 trial sites

  • Bioequivalence무코란서방정150밀리그램(레바미피드)2024-03-18

    2 trial sites

  • Bioequivalence펜틴정(펜디메트라진타르타르산염)2023-05-01

    2 trial sites

  • Bioequivalence페스틴정(펜터민염산염)2023-04-21

    2 trial sites

  • Bioequivalence엘피진정(레보드로프로피진)2022-12-09

    2 trial sites

  • Phase 1DHNP-20012022-03-28

    1 trial site

  • Phase 1DHNP-20012022-02-23

    1 trial site

  • Bioequivalence다파포민서방정10/500밀리그램2022-01-04

    2 trial sites

Show 17 more
  • Bioequivalence다파포민서방정10/500밀리그램2021-12-29

    2 trial sites

  • Bioequivalence다파포민서방정10/1000밀리그램2021-09-29

    2 trial sites

  • Bioequivalence다파포민서방정10/1000밀리그램2021-07-14

    2 trial sites

  • Bioequivalence뉴피도정(클로피도그렐황산수소염)2021-03-11

    2 trial sites

  • Bioequivalence엔피다파정10밀리그램(다파글리플로진프로판디올수화물)2020-12-28

    2 trial sites

  • Bioequivalence에스오엠정40mg(에스오메프라졸마그네슘삼수화물)2020-11-03

    2 trial sites

  • Bioequivalence클래마신정500mg(클래리트로마이신)2020-05-12

    2 trial sites

  • Bioequivalence뉴토젯정10/40mg2020-01-30

    2 trial sites

  • Bioequivalence아세파인정(아세클로페낙)2019-09-30

    2 trial sites

  • Bioequivalence티파론정(티로프라미드염산염)2019-08-20

    2 trial sites

  • Bioequivalence모사가틴정(모사프리드시트르산염수화물)2019-07-17

    2 trial sites

  • Bioequivalence뉴스토정20mg(로수바스타틴칼슘)2017-11-28

    2 trial sites

  • Bioequivalence알포익정(알티옥트산트로메타민염)2017-02-22

    2 trial sites

  • Bioequivalence엔피포지정10/160밀리그램2016-08-30

    2 trial sites

  • Bioequivalence뉴토르정20밀리그램(아토르바스타틴칼슘)2015-11-02

    2 trial sites

  • Bioequivalence디프렌캡슐(플루옥세틴염산염)2015-07-16

    2 trial sites

  • Bioequivalence토피트정(토피라메이트)2015-01-09

    2 trial sites

Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

HUONS CO., LTD.1 shared

KOSDAQ-listed pharmaceutical and healthcare company producing lidocaine anesthetics and the Kynix hyaluronic-acid eye-drop line.

NUON CO., LTD.1 shared

KOSDAQ-listed healthcare company selling the Cissus weight-management ingredient and Sallimbaekseo household products.

L&C BIO Co., Ltd1 shared

L&C BIO manufactures human tissue grafts across 11 tissue types, including the acellular dermal matrix MegaDerm, plus tissue-based medical devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.1 shared

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

Hanmi Pharm. Co., Ltd.1 shared

KOSPI-listed pharmaceutical company behind the combination drugs Amosartan (hypertension) and Rosuzet (dyslipidemia).

BASKHANBIOPharma Inc.1 shared

Founded 1986, KONEX-listed since 2022, BASKHANBIOPharma makes drugs and medical devices for use before and after surgery.

DongBang Medical Co., Ltd.1 shared

KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.

Medy-Tox Inc.1 shared

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

JETEMA Co.,Ltd.1 shared

Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.

Hironic Co.,Ltd1 shared

KOSDAQ-listed medical device company producing HIFU devices DOUBLO/V-RO and the Synerjet non-invasive drug delivery system for aesthetic dermatology.

CAREGEN CO.,LTD.1 shared

CAREGEN develops peptide-based cosmeceuticals sold in 130 countries and ophthalmic drug candidates CG-P5 and CG-T1.

JW SHINYAK CORPORATION1 shared

A pharmaceutical company supplying antifungal and urology drugs to clinics, co-marketing original drugs together with JW Pharmaceutical.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition